[1]
Barszczewska, O. et al. 2020. Biosimilars in the French and Polish System: Chosen Aspects of Reimbursement and Access. Comparative Economic Research. Central and Eastern Europe. 23, 2 (Jun. 2020), 103–115. DOI:https://doi.org/10.18778/1508-2008.23.15.